BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04738487-completion@plaintrial.com
DTSTAMP:20261027T103146Z
DTSTART;VALUE=DATE:20260127
SUMMARY:Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembr
 olizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1
 ) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003\, KEYVIBE-0
 03) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04738487
URL:https://plaintrial.com/trial/NCT04738487
END:VEVENT
END:VCALENDAR